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Abstract 
Analyzing who is likely to be readmitted and understanding some key factors contributing to preventable readmissions in 
hospitals is being widely researched, but few studies have examined the role of clinical disease markers in predicting frequent 
readmissions related to disease progression. In this study, we explore 7-day readmission risk prediction using data on patients’ 
creatinine levels, a key laboratory marker of serious illness, as a potential predictor of future readmission for patients with a large 
number of repeat hospital visits. Using Electronic Health Record data on 5,103 patients, we explore prediction of readmission 
using a multivariate logistic regression model. Preliminary results suggest three significant components impacting the 
readmission occurrence: age, gender and creatinine levels. Further research will incorporate other disease markers using data 
mining methods, combined with time-invariant and time-varying covariates, to identify more insightful set of longitudinal factors 
for readmission risk reduction. 
© 2016 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the Conference Program Chairs. 
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1. Introduction 
The problem of hospital readmission, wherein some patients return shortly after they are discharged and are 
readmitted for the same or related condition, has become a challenge worldwide from both care quality and financial 
perspectives1. Predicting who is likely to be readmitted and understanding the factors contributing to preventable 
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readmissions is a critical problem that is being widely investigated2. This study proposes an approach for assessing 
the potential factors leading to readmission instances. In particular, based on a clinical marker which is a routinely 
collected laboratory test result, we seek to understand how readmission risk may progress over many separate 
hospital admissions. These insights may help physicians and hospital management to develop early interventions to 
identify and treat patients at high risk of readmissions. 
2. Background 
In Israel, an advanced information technology enabled healthcare delivery system and universal coverage have led 
to readmission rates being relatively stable in the last decade3. In 2011, out of approximately 130,000 
hospitalizations, about 19,000 patients (an estimated 14%) were readmitted within 7 days. Factors influencing 
readmission were identified as age, gender (men had 1.13 higher likelihood of readmission) and length of stay of 5 
to 7 days during the initial admission (chances of readmission increased by 1.28)3. Israel’s ministry of health has 
deployed an incentive program for health maintenance organizations (HMOs) implementing initiatives to reduce 
readmissions, including extensive use of health information technology. To facilitate readmission reduction, 
physicians send the patient’s medical records through a Health Information Exchange (HIE) to the relevant 
clinicians in the community. Past findings have shown that electronic health record (EHR) use reduces readmissions 
after seven days4,5. Policy implications and concrete steps to prevent readmissions are also starting to emerge. 
However, despite these efforts, readmission rates remain unacceptably high6. 
Models of patient level factors such as medical comorbidities, basic demographic data, and clinical variables are 
much better able to predict mortality than readmission risk7-9. Broader social, environmental, and medical factors 
such as access to care, social support, substance abuse, and functional status contribute to readmission risk in some 
models, but the utility of such factors has not been widely studied10. A recent study has found that health IT usage, 
patient demographics, visit characteristics, payer type, and hospital characteristics, are all significantly associated 
with patient readmission risk in the context of Congestive Heart Failure (CHF)2. However, with healthcare 
organizations operating under constrained resources, there is increasing interest in identifying patients at the highest 
risk of costly complications and readmissions using routinely collected laboratory data11,12. In this study, we 
investigate the role of patients’ creatinine level, routinely obtained via a blood test for most emergency and 
hospitalized patients, in tracking and identifying patients at high risk of readmission. In contrast to our prior work 
using longitudinal data13, we apply logistic regression to predict readmission risk and elicit risk factors relevant for 
addressing this challenge. 
The level of serum creatinine in the blood is a key indicator of kidney function, which is tested almost every time a 
patient has a hospital stay. Increased creatinine levels in the blood point to possible diseases or conditions that affect 
kidney function and frequently lead to hospitalizations. Multiple studies have shown that creatinine level is an 
important indicator for tracking readmission risk in patients with heart disease14-16. In this study, we use creatinine 
results (retrieved from the EHR) for each patient who had between seven and twelve hospitalizations during the 
study period of four years, which provided sufficient data from a sizeable population to extract preliminary insights. 
3. Methods 
This study is based on data from the largest HMO in the State of Israel, listed as one of the world’s largest non-
governmental HMOs. The data includes patients’ demographics, medications, adverse reactions, sensitivities, lab 
and imaging results, past diagnoses, and healthcare procedures.  
We extracted data from the EHR systems of several Emergency Departments (ED) across Israel. In this preliminary 
study, in order to test our hypothesis that laboratory results such as creatinine values can be useful in monitoring 
patients who are at higher risk of readmissions, we selected 5,103 patients who experienced hospital admissions for 
varied conditions and at least one readmission episode. We targeted creatinine levels from their laboratory results 
for analysis of potential progression in the severity of the patient’s health condition over time and many visits that 
may indicate increased likelihood of readmission. We explore risk stratification and prediction using multivariate 
logistic regression modelling and analysis. 
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Our model uses a binary dependent variable, yi, representing readmission occurrence (1=readmission; 0=non-
readmission). The log model is: 
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Defining πi = P(yi=1) and 1 – πi = P(yi=0), we have 
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represents the odds of the event y i =1 occurring.  Therefore, as commonly reported, 
the odds ratio (OR) is presented in the results in Table 2. 
 
4. Results 
We present two sets of results in this study. The first summarizes some useful descriptive statistics associated with 
the 5,103 patient records that were analyzed.  
Table 1 provides a brief summary of the key features about patients and their visits to the hospital EDs that are 
captured in the data. Males have significantly higher average creatinine levels and higher 7-day readmissions (not 
significant).  
 
Table 1. Characteristics of the study sample and comparison between male and female subjects 
Data characteristics Study sample 
n=5,103 
Male 
n=2,528 (49.5%) 
Female 
n=2,575 (50.5%) 
Significance 
Age 64.86±19.76 65.78±18.58 63.98±20.8 0.001 
Insurance (main HMO %) 89% 89% 90% 0.55 
Creatinine result 1.4±1.28 1.61±1.38 1.2±1.13 <0.001 
Average number of 7-day 
readmissions  
1.68±0.98 1.7±0.99 1.65±0.96 0.077 
     Note: Data are the mean (±SD) or number of subjects (proportion) 
 
 
 
 
 
 
(1) 
(2) 
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Table 2. Logistic regression results for the independent variable ‘readmission within 7 days’ 
95.0% C.I. for Exp (B) OR Sig. df Wald S.E. B Variables in the 
Equation* Upper Lower    
1.044 1.011 1.027 .001 1 10.518 .008 .027 Creatinine 
Result** 
.998 .996 .997 .000 1 20.253 .001 -.003 Age*** 
1.105 1.008 1.055 .021 1 5.317 .023 .054 Gender* 
1.076 .928 .999 .982 1 .001 .038 -.001 Insurance 
  .150 .000 1 1369.23 .051 -1.897 Constant*** 
The regression results for 7-day readmissions are shown in Table 2. They indicate that when patients’ creatinine 
values increase by one unit, the likelihood of readmission increases by 2.7% (95% CI=1.011-1.044, adjusted 
OR=1.027). 
When the age of the patients increases by one year, the likelihood of readmission decreases by 0.3% (95% 
CI=0.996-0.998, adjusted OR=0.997). 
For male patients, the likelihood of admissions to the ED increases by 5.5% in comparison to female patients (95% 
CI=1.008-1.105, adjusted OR=1.055). 
When the insured patients are not members of the main HMO, the likelihood of admissions increases by 0.1%, but is 
not significant (95% CI=0.928-1.076913, adjusted OR=0.999). 
5. Discussion and Conclusions 
The objective of this preliminary study was to utilize a clinical marker of disease progression in assessing the 
potential factors leading to hospital readmission instances. The regression model results display 7-day readmission 
rates that were affected by age, gender and creatinine levels. Furthermore, this preliminary model and results can be 
further expanded to generate valuable insights regarding other significant covariates that may impact readmission 
risk. Finally, the findings may enable policy makers to better understand the potential of interoperability between 
various points of care, showing the value of information regarding laboratory tests and its potential to forecast 
readmission. This could promote the utilization and implementation of such systems. 
  
The study has some limitations. One limitation is that our model includes only a single variable associated with a 
laboratory marker. Future research will investigate other clinical markers of complex diseases such as blood sugar 
levels and cholesterol levels of patients at the time of admission, as well as additional time-invariant risk factors 
such as diagnoses and procedures that indicate the severity and complexity of the patient’s health condition. This 
can also be captured via a disease severity measure such as the Charlson comorbidity index17. Another limitation is 
that the current model does not include time-varying factors such as critical vitals at each admission and discharge, 
which may facilitate more nuanced risk prediction for frequent readmissions. These and other extensions, such as 
the use of the LaCE score index9, will be explored in future research. 
Acknowledgements 
This research was supported by Grant No 2015153 from the United States-Israel Binational Science Foundation 
(BSF). 
 
 
* *** p<0.001, ** p<0.01, *p<0.05, + p<0.1 
361 Ofi r Ben-Assuli et al. /  Procedia Computer Science  98 ( 2016 )  357 – 361 
 
References  
1. Kociol RD, Lopes RD, Clare R, Thomas L, Mehta RH, Kaul P, et al. International variation in and factors 
associated with hospital readmission after myocardial infarction. JAMA. 2012;307(1):66-74. 
2. Bardhan IR, Oh JH, Zheng Z, Kirksey K. Predictive Analytics for Readmission of Patients with Congestive 
Heart Failure. Information Systems Research. 2014;26(1):19-39. 
3. Haklai Z, Maron J, Aborva M, Gordon S, Zeltz I, Apelboim Y. Admissions to Internal Deparments 2000-
2012. In: The Ministry of Health I, editor. Jerusalem2013. 
4. Ben-Assuli O, Shabtai I, Leshno M. The impact of EHR and HIE on reducing avoidable admissions: 
controlling main differential diagnoses. BMC medical informatics and decision making. 2013;13(1):49. 
5. Ben-Assuli O, Shabtai I, Leshno M, Hill S. EHR in Emergency Rooms: Exploring the Effect of Key 
Information Components on Main Complaints. Journal of medical systems. 2014;38(4):1-8. 
6. Meydan C, Haklai Z, Gordon B, Mendlovic J, Afek A. Managing the increasing shortage of acute care 
hospital beds in Israel. Journal of evaluation in clinical practice. 2015;21(1):79-84. 
7. Hammill BG, Curtis LH, Fonarow GC, Heidenreich PA, Yancy CW, Peterson ED, et al. Incremental value 
of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. Circulation: 
Cardiovascular Quality and Outcomes. 2011;4(1):60-7. 
8. Amarasingham R, Moore BJ, Tabak YP, Drazner MH, Clark CA, Zhang S, et al. An automated model to 
identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Medical 
care. 2010;48(11):981-8. 
9. van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, et al. Derivation and validation of an 
index to predict early death or unplanned readmission after discharge from hospital to the community. Canadian 
Medical Association Journal. 2010;182(6):551-7. 
10. Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, et al. Risk prediction models 
for hospital readmission: a systematic review. Jama. 2011;306(15):1688-98. 
11. Malone B. The Race to Reduce Readmissions: Can Lab Tests Help Predict Who Will Return to the 
Hospital? Clinical Laboratory News. 2013. 
12. Brunisholz KD, Kfoury AG, Rasmusson K, Bair T, Budge D, Alharethi R, et al. Exceptional predictive 
ability of the Intermountain Risk Score (IMRS) for hospital re-admission after heart failure (HF) discharge. Journal 
of Heart Lung Transplan. 2012;31(4S):155. 
13. Ben-Assuli O, Padman R, Bowman M, Leshnod M, Shabtai I, editors. On Analyzing Readmissions Using 
Group-Based Trajectory Model: Evidence From Israel. WITS 2015 - Workshop of Information Technology and 
Systems; 2015; Dallas, TX. 
14. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ, Committee ASA. Risk stratification 
for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. Jama. 
2005;293(5):572-80. 
15. Krumholz HM, Chen Y-T, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission 
among elderly survivors of admission with heart failure. American heart journal. 2000;139(1):72-7. 
16. Price JD, Romeiser JL, Gnerre JM, Shroyer ALW, Rosengart TK. Risk analysis for readmission after 
coronary artery bypass surgery: developing a strategy to reduce readmissions. Journal of the American College of 
Surgeons. 2013;216(3):412-9. 
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in 
longitudinal studies: development and validation. Journal of chronic diseases. 1987;40(5):373-83. 
 
